Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
By T. Walsh, S. Casadei, Ming K. Lee, C. Pennil, A. Nord, A. Thornton, Wendy Roeb, K. Agnew, S. Stray, A. Wickramanayake and 5 more. Proceedings of the National Academy of Sciences of the United States of America, 2011
918 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/35ad446cb633930e50498b34a62862f76998407c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
Citations in the corpus
- Homologous recombination and human health: the roles of BRCA1, BRCA2 and associated proteins (2015, background): “Monoallelic PALB2 mutations have also been associated with pancreatic and ovarian cancer susceptibility (Jones et al. 2009; Walsh et al. 2011).”
- Inherited Mutations in Women with Ovarian Carcinoma (2016, positive): “Clinical Characteristics and Mutation Status Ovarian cancer–associated mutations were separated into 5 categories: (1) BRCA1, (2) BRCA2, (3) other BRCA-Fanconi anemia OC–associated (BRIP1, PALB2, RAD51C, RAD51D, BARD1), (4) mismatch repair (MSH6, PMS2, MSH2, MLH1), and (5) and no mutation (either a ”
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas (2013, positive): “Sequence alignment and variant calling were performed against the reference human genome (UCSC hg19) as previously described (1).”